[go: up one dir, main page]

GB9920578D0 - Composition for maintenance of bone or dental health or treatment of bone or dental disorders - Google Patents

Composition for maintenance of bone or dental health or treatment of bone or dental disorders

Info

Publication number
GB9920578D0
GB9920578D0 GBGB9920578.3A GB9920578A GB9920578D0 GB 9920578 D0 GB9920578 D0 GB 9920578D0 GB 9920578 A GB9920578 A GB 9920578A GB 9920578 D0 GB9920578 D0 GB 9920578D0
Authority
GB
United Kingdom
Prior art keywords
bone
dental
maintenance
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9920578.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Priority to GBGB9920578.3A priority Critical patent/GB9920578D0/en
Publication of GB9920578D0 publication Critical patent/GB9920578D0/en
Priority to AU68385/00A priority patent/AU6838500A/en
Priority to PCT/EP2000/007919 priority patent/WO2001015715A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9920578.3A 1999-08-31 1999-08-31 Composition for maintenance of bone or dental health or treatment of bone or dental disorders Ceased GB9920578D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9920578.3A GB9920578D0 (en) 1999-08-31 1999-08-31 Composition for maintenance of bone or dental health or treatment of bone or dental disorders
AU68385/00A AU6838500A (en) 1999-08-31 2000-08-14 Composition for maintenance of bone or dental health or treatment of bone or dental disorders
PCT/EP2000/007919 WO2001015715A2 (en) 1999-08-31 2000-08-14 Composition for maintenance of bone or dental health or treatment of bone or dental disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9920578.3A GB9920578D0 (en) 1999-08-31 1999-08-31 Composition for maintenance of bone or dental health or treatment of bone or dental disorders

Publications (1)

Publication Number Publication Date
GB9920578D0 true GB9920578D0 (en) 1999-11-03

Family

ID=10860095

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9920578.3A Ceased GB9920578D0 (en) 1999-08-31 1999-08-31 Composition for maintenance of bone or dental health or treatment of bone or dental disorders

Country Status (3)

Country Link
AU (1) AU6838500A (en)
GB (1) GB9920578D0 (en)
WO (1) WO2001015715A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100866008B1 (en) 1999-10-19 2008-10-29 메이지 데어리즈 코포레이션 Preventives/remedies for metabolic bone diseases
JP4268785B2 (en) * 2002-04-11 2009-05-27 株式会社ロッテ Calcium absorption promoter and calcium phosphate crystal growth promoter
US7517681B2 (en) 2003-01-29 2009-04-14 Biogaia Ab Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
US6872565B2 (en) 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries
JP2004315477A (en) * 2003-04-18 2004-11-11 Tokyoto Koreisha Kenkyu Fukushi Shinko Zaidan Bone resorption inhibitor
WO2006000992A1 (en) * 2004-06-23 2006-01-05 L'oreal Method and compositions useful for preventing and/or treating sensitive and/or dry skin
FR2872047B1 (en) * 2004-06-23 2007-06-15 Oreal COMPOSITION FOR SENSITIVE SKINS COMBINING MINERAL AND PROBIOTIC CATION (S)
US7956031B2 (en) 2005-05-31 2011-06-07 Naidu Lp Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
SE529199C2 (en) 2005-07-05 2007-05-29 Probi Ab Increased absorption
US8021659B2 (en) 2006-04-28 2011-09-20 Naidu Lp Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
FR2920305B1 (en) 2007-09-04 2010-07-30 Oreal USE OF A SPECIFIC BIFIDOBACTERIUM LYSATE FOR THE TREATMENT OF SENSITIVE SKINS.
FR2920304B1 (en) 2007-09-04 2010-06-25 Oreal COSMETIC USE OF LYSAT BIFIDOBACTERIUM SPECIES FOR THE TREATMENT OF DROUGHT.
US9603876B2 (en) 2008-09-25 2017-03-28 New York University Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment
FR2942719B1 (en) 2009-03-04 2011-08-19 Oreal USE OF PROBIOTIC MICROORGANISMS TO LIMIT SKIN IRRITATION
US20120237635A1 (en) * 2009-09-17 2012-09-20 Danone, S.A. Pasteurised and fermented dairy product supplemented with calcium and vitamin d and procedure for preparing such product
ES2365145B1 (en) * 2009-09-17 2012-09-13 Danone, S.A. FERMENTED PASTERIZED DAIRY PRODUCT AND PREPARATION PROCEDURE OF THE SAME.
US8951512B2 (en) * 2010-05-04 2015-02-10 New York University Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
US9386793B2 (en) 2010-08-20 2016-07-12 New York University Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
MX371418B (en) 2013-04-03 2020-01-29 Probi Ab Probiotic strains for use in treatment or prevention of osteoporosis.
CN104152354A (en) * 2013-05-14 2014-11-19 仙农生物科技(上海)有限公司 Compound probiotics as well as production process and application thereof to leavening agent
JP6908998B2 (en) 2013-07-05 2021-07-28 ステラー・バイオウム・インコーポレーテッド Oral composition
CN104186655B (en) * 2014-08-27 2016-06-29 内蒙古伊利实业集团股份有限公司 There is low-fat yogurt of blood fat reducing and anti-oxidation function and preparation method thereof
US10653728B2 (en) 2016-10-17 2020-05-19 New York University Probiotic compositions for improving metabolism and immunity
CN106858605A (en) * 2016-12-26 2017-06-20 吉林舒润生物科技有限公司 A kind of probiotics calcium functional food for preventing and treating bone information relevant disease
CN108245479B (en) * 2017-09-19 2020-11-20 魏珂 Facial mask containing bifidobacterium lactis fermented active extract
EP3812452A4 (en) 2018-09-30 2021-11-03 Inner Mongolia Yili Industrial Group Co., Ltd. BIFIDOBACTERIUM LACTIS BL-99 AND ITS USES
CN110964656B (en) * 2018-09-30 2021-05-28 内蒙古伊利实业集团股份有限公司 Bifidobacterium lactis BL-99 capable of preventing osteoporosis and application thereof
JP7596301B2 (en) * 2019-12-02 2024-12-09 雪印メグミルク株式会社 Bone strengthening agent
KR102198552B1 (en) 2020-06-09 2021-01-05 주식회사 비피도 Composition improving, preventing or treating halitosis or dental caries comprising Lactobacillus fermentum OK derived from human oral cavity
KR102198553B1 (en) 2020-06-09 2021-01-05 주식회사 비피도 Composition improving, preventing or treating halitosis or dental caries comprising Lactobacillus gasseri HHuMIN D derived from human oral cavity
CN114711355A (en) * 2022-04-21 2022-07-08 暨南大学 Compound organic acid high calcium probiotic drink using astragalus polysaccharide as raw material and preparation method and application
CN116904378B (en) * 2023-09-14 2023-12-29 山东中科嘉亿生物工程有限公司 Lactobacillus johnsonii JYLO-010 for promoting bone growth, microbial inoculum and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273485A3 (en) * 1986-11-25 1988-07-27 Verenigde Coöperatieve Melkindustrie Coberco B.A. A process for preparing a raw material for human food; human food; a process for preparing a pharmaceutical composition
US5785990A (en) * 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same

Also Published As

Publication number Publication date
AU6838500A (en) 2001-03-26
WO2001015715A3 (en) 2001-10-18
WO2001015715A2 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
GB9920578D0 (en) Composition for maintenance of bone or dental health or treatment of bone or dental disorders
PL351134A1 (en) Compositions for treatment of disorders of the oesophagus
IL147440A0 (en) Composition for treatment of external secretion disorders
HUP9802319A3 (en) Pharmaceutical compositions for treatment of bone deficit conditions
WO2002086502A8 (en) Methods for the diagnosis and treatment of bone disorders
IL157734A0 (en) Pharmaceutical compositions for the treatment of urogenital disorders
PL344304A1 (en) Combination therapy for treatment of bipolar disorders
AU7434101A (en) Treatment of bone diseases
HUP0401427A3 (en) Oral compositions for the treatment of scalp disorders
HUP0104963A3 (en) Compositions for the treatment of skin diseases
EP1173470A4 (en) Treatment of bone disorders with adrenomedullin or adrenomedullin agonists
IL146131A0 (en) Treatment of neurotic disorders
AU2002362115A8 (en) Composition and methods for treatment of neurological disorders
EP1420718A4 (en) Resorbable prosthesis for medical treatment
HUP0402267A3 (en) Method for treatment of bone disorders
HUP0204258A3 (en) Use of vitamin d-derivatives for preparation of pharmaceutical compositions useful in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives
HUP0101748A3 (en) Use of reboxetine for producing pharmaceutical compositions suitable for treating nervous disorders
EP1440163A4 (en) Methods and compositions for the treatment and diagnosis of pain disorders using 46566
GB9904252D0 (en) Composition for the treatment of pain
EP1440169A4 (en) Methods and compositions for the treatment and diagnosis of pain disorders using 57749
EP1439862A4 (en) Methods and compositions for the treatment and diagnosis of pain disorders using 9805
TWI345980B (en) Pharmaceutical compositions for preventing or treating injuries of brain tissue
AU2003245011A8 (en) Method and compositions for treatment of bone disorders
EP1448152A4 (en) Methods and compositions for the treatment and diagnosis of pain disorders using 2047
GB9918000D0 (en) Compositions for the treatment of pain

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)